Redesigned Process in the Operating Room

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 18, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Non-operative TimeGeneral Surgery, Above 18 Years of Age
Interventions
PROCEDURE

Patients will be inducted in the induction room

The patients will be inducted in the induction room

PROCEDURE

Redesigned process

The registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room

DRUG

patient will be reversed with sugammadex 4mg/kg IV

The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR

PROCEDURE

STANDARD PROCESS

standard process

Trial Locations (1)

Unknown

American University of Beirut Medical Center, Beirut

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

American University of Beirut Medical Center

OTHER

NCT01937247 - Redesigned Process in the Operating Room | Biotech Hunter | Biotech Hunter